Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.41 - $0.63 $28 - $43
-69 Reduced 0.43%
16,000 $9,000
Q4 2021

Feb 15, 2022

BUY
$0.57 - $1.29 $9,159 - $20,729
16,069 New
16,069 $9,000
Q3 2021

Nov 10, 2021

SELL
$1.11 - $1.7 $17,760 - $27,200
-16,000 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$1.46 - $2.25 $23,360 - $36,000
16,000 New
16,000 $27,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $313M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Wellington Shields Capital Management, LLC Portfolio

Follow Wellington Shields Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.